Drug intelligence / Profile preview

shensu ganmao

Development stage: Unknown
Lead developer: Guangdong Huarun Shunfeng Pharmaceutical
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Shensu Ganmao (also referred to as Shensunanmin in some clinical trial contexts) is a Traditional Chinese Medicine (TCM) formulation developed by Guangdong China Resources Shunfeng Pharmaceutical for the treatment of the common cold and allergic rhinitis. Based on the classical "Shen Su Yin" formula, it typically contains a combination of herbal extracts including Ginseng (*Radix Ginseng*), Perilla Leaf (*Folium Perillae*), Pueraria (*Radix Puerariae*), Peucedanum (*Radix Peucedani*), Poria (*Poria*), Bitter Orange (*Fructus Aurantii*), Platycodon (*Radix Platycodonis*), Scutellaria (*Radix Scutellariae*), Pinellia (*Rhizoma Pinelliae*), and Glycyrrhiza (*Radix Glycyrrhizae*). The formulation is specifically indicated for resolving the exterior, transforming phlegm, and supplementing Qi, making it suitable for cold symptoms in patients with underlying Qi deficiency. A Phase 1 clinical trial (CTR20170614) was conducted in China to evaluate the safety, tolerability, and preliminary pharmacodynamics of the tablet formulation in adults with the common cold.

Brand names: 参苏感冒片
Other names: ShensunanminShensu GanmaoShensu Ganmao PianShen Su Yin

Beyond the preview

Go deeper on shensu ganmao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on shensu ganmao.

Explore the full profile